SPOTLIGHT -
Dr. Ruddy on the Use of GnRH Agonists in Breast Cancer
Kathryn Ruddy, MD, discusses the use of GnRH agonists in breast cancer.
Read More
Dr. Ruddy on the Management of CNS Metastases in HER2+ Breast Cancer
Kathryn Ruddy, MD, associate professor of Oncology, Mayo Clinic, discusses the management of central nervous system (CNS) metastases in HER2-positive breast cancer.
Dr. Ruddy on the Importance of Genetic Testing in Breast Cancer
Kathryn Ruddy, MD, discusses how genetic testing could impact treatment of patients with breast cancer.
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
